Bsw Wealth Partners Penumbra Inc Transaction History

Bsw Wealth Partners

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$220.43 - $278.69 $71,639 - $90,574	-325 Reduced 24.66%	993 $276,000
Q4 2022 Feb 13, 2023	BUY	$151.88 - $228.5 $21,566 - $32,447	142 Added 12.07%	1,318 $292,000
Q3 2022 Nov 14, 2022	BUY	$120.36 - $205.88 $141,543 - $242,114	1,176 New	1,176 $223,000
Q2 2022 Aug 15, 2022	SELL	$116.09 - $227.33 $112,375 - $220,055	-968 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$187.51 - $283.98 $49,502 - $74,970	-264 Reduced 21.43%	968 $215,000
Q4 2021 Feb 14, 2022	BUY	$238.08 - $288.0 $13,808 - $16,704	58 Added 4.94%	1,232 $354,000
Q3 2021 Nov 15, 2021	BUY	$250.72 - $291.24 $41,368 - $48,054	165 Added 16.35%	1,174 $313,000
Q2 2021 Aug 16, 2021	BUY	$235.0 - $310.7 $237,115 - $313,496	1,009 New	1,009 $277,000

373

29.1M

305K

192K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.09B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Bsw Wealth Partners, based on Form 13F filings with the SEC.

Stay updated on Bsw Wealth Partners with notifications on news.